(Q44242814)

1 December 2017

title

Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients (English)

1 reference

1 December 2017

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

John Yoo

1

1 reference

1 December 2017

Scott J Hamilton

2

1 reference

1 December 2017

Douglas Angel

3

1 reference

1 December 2017

Kevin Fung

4

1 reference

1 December 2017

Jason Franklin

5

1 reference

1 December 2017

Lorne S Parnes

6

1 reference

1 December 2017

Denise Lewis

7

1 reference

1 December 2017

Varagur Venkatesan

8

1 reference

1 December 2017

Eric Winquist

9

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

1 December 2017

1 reference

1 December 2017

volume

124

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

E87-94

1 reference

High-dose cisplatin in patients with advanced malignancies.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: current standards and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

cis-platinum ototoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Cisplatin: evaluation of its ototoxic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Changes in the stria vascularis of the guinea pig due to cis-platinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Ototoxic protection of sodium thiosulfate: daily vs constant infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Mechanism of cisplatin ototoxicity: antioxidant system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Application of antioxidants and other agents to prevent cisplatin ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

4-Methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

D-methionine provides excellent protection from cisplatin ototoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

D-Methionine protects against cisplatin damage to the stria vascularis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Round window application of D-methionine provides complete cisplatin otoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Clinical pharmacokinetics of N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Acetaminophen and acetylcysteine dose and duration: past, present and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Intravenous acetylcysteine for the treatment of acetaminophen overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Intratympanic steroids for inner ear disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Introduction to sample size determination and power analysis for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24360

21 January 2018

Identifiers

DOI

10.1002/LARY.24360

1 reference

1 December 2017

1 reference